Capital expenditure · 2011–2025
Bio-Techne capital expenditure
$31.0M−50.7% · FY2025
Bio-Techne (TECH) reported $31.0M in capital expenditure for fiscal 2025, −50.7% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-06-30 | $31.0M | −50.7% | Open → |
| FY20242024-06-30 | $62.9M | +64.4% | Open → |
| FY20232023-06-30 | $38.2M | −14.8% | Open → |
| FY20222022-06-30 | $44.9M | +1.4% | Open → |
| FY20212021-06-30 | $44.3M | −14.4% | Open → |
| FY20202020-06-30 | $51.7M | +103.6% | Open → |
| FY20192019-06-30 | $25.4M | +21.4% | Open → |
| FY20182018-06-30 | $20.9M | +37.9% | Open → |
| FY20172017-06-30 | $15.2M | −10.2% | Open → |
| FY20162016-06-30 | $16.9M | −15.1% | Open → |
| FY20152015-06-30 | $19.9M | +44.0% | Open → |
| FY20142014-06-30 | $13.8M | −38.4% | Open → |
| FY20132013-06-30 | $22.5M | +273.2% | Open → |
| FY20122012-06-30 | $6.0M | +65.8% | Open → |
| FY20112011-06-30 | $3.6M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +16.6%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Bio-Techne capital expenditure |url=https://companiesranked.com/en/company/bio-techne/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Bio-Techne capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/bio-techne/capital-expenditureBibTeX
@misc{companiesranked-en-company-bio-techne-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Bio-Techne capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/bio-techne/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001104659-26-100322 · August 24, 2026
{{cite web |title=Bio-Techne capital expenditure — 10-K (0001104659-26-100322) |url=https://www.sec.gov/Archives/edgar/data/842023/000110465926100322/tech-20260630x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.